Skip to main content
. 2023 Jun 6;49(6):645–655. doi: 10.1007/s00134-023-07098-5
In different types of cardiocirculatory shock, considering sublingual microcirculatory perfusion variables in the therapeutic management has been proposed to improve outcome. In this prospective randomized-controlled multicenter study, integrating sublingual microcirculatory perfusion variables in the therapy plan resulted in significantly more treatment changes that did not improve 30-day survival.